Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-03-14-Speech-3-354-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-03-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"lt"^^xsd:language2
lpv:document identification number	"en.20120314.22.3-354-000"2
lpv:hasSubsequent	lp_eu:2012-03-14-Speech-3-355-0002
lpv:speaker	lp:Vilija Blinkevičiūtė2
lpv:spokenAs	substitute; FEMM (2012-01-19--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 vice-chair; Delegation to the EU-Ukraine Parliamentary Cooperation Committee (2009-09-29--2014-06-30)3 member; EMPL (2012-01-19--2014-06-30)3 member; Delegation to the Euronest Parliamentary Assembly (2009-10-07--2014-06-30)3 substitute; LIBE (2012-01-19--2014-06-30)3 unknown; Lietuvos socialdemokratų partija (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3
lpv:translated text	"I voted in favour of this European Parliament resolution because diabetes is one of the most common non-communicable diseases. It is estimated that it affects more than 32 million EU citizens, representing nearly 10% of the total EU population, with an additional 32 million citizens suffering from impaired glucose tolerance and with a very high probability of progressing to clinically manifest diabetes. Diabetes is a leading cause of heart attacks, strokes, blindness, amputation and kidney failure, if poorly managed or diagnosed too late. Unfortunately, there is a lack of funding and infrastructure to coordinate diabetes research in the EU, impacting negatively on the competitiveness of EU diabetes research and preventing people with diabetes in Europe from benefiting fully from research. The European Parliament therefore calls on the Commission to develop and implement a targeted EU diabetes strategy on diabetes prevention, diagnosis, management, education and research. The Member States should develop, implement and monitor national diabetes programmes, aimed at health promotion, risk factor reduction, improved prediction, prevention, early diagnosis, and treatment of diabetes, targeting both the population at large and high-risk groups, and aimed at reducing inequalities and optimising health care resources."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph